FUDESIX

UNIVADIS - FUDESIX /univadis/FUDESIX.md

ATC

Μορφές: ORAL.SOL

Δραστικές

Δελτίο Τιμών 05/2018

Ημερομηνία barcode code περιεχομενο τιμή παραγωγός χονδρική λιανική
05/2018 2802740401011 274040101 FUDESIX ORAL.SOL 20MG/5ML BTx1 BOTTLEx150 ML 4.15 4.35 6.00
05/2018 2802740403015 274040301 FUDESIX ORAL.SOL 50MG/5ML BTx1 BOTTLEx150 ML 6.53 6.85 9.45
  • DRUGBANK - Nitrofurazone
  • indication:

    For the treatement of bacterial skin infections including pyodermas, infected dermatoses and infections of cuts, wounds, burns and ulcers due to susceptible organisms.

  • pharmacology:

  • mechanism:

    The exact mechanism of action is unknown. Nitrofurazone inhibits several bacterial enzymes, especially those involved in the aerobic and anaerobic degradation of glucose and pyruvate. This activity is believed also to affect pyruvate dehydrogenase, citrate synthetase, malate dehydrogenase, glutathione reductase, and pyruvate decarboxylase.

  • toxicity:

    Rat LD<sub>50</sub> = 590 mg/kg; Allergic contact dermatitis is the most frequently reported adverse effect, occurring in approximately 1 % of patients treated.

  • absorprion:

    Well absorbed.

  • halflife:

    5 hours

  • roouteelimination:

  • volumedistribution:

  • clearance: